Atheneos Ventures is a US-based, healthcare-focused venture capital firm and fund advisor operating primarily as an evergreen investment vehicle supporting early-stage life sciences companies; the firm concentrates on high-risk, high-impact medical innovation, with a historical focus on disease treatment and a more recent emphasis on orphan drugs and rare diseases through affiliated structures; its investment approach centers on early identification of biotechnology and healthcare startups with long development cycles and significant clinical upside; the firm typically invests across biotechnology, pharmaceuticals, clinical trials, and health technology sectors, often participating in syndicate rounds alongside other life sciences investors; overall it functions as a specialized healthcare venture capital platform focused on translational medicine and drug development innovation.